Annual Results Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
EQUITY AND LIABILITIES
No of Months
12
12
Share Capital
5.89
1.47
Share Warrants & Outstandings
Total Reserve
249.97
156.22
Shareholder's Funds
255.86
157.69
Minority Interest
0.00
0.00
Long-Term Borrowings
3.69
3.21
Secured Loans
2.14
1.44
Unsecured Loans
1.55
1.77
Deferred Tax Assets / Liabilities
22.90
11.16
Other Long Term Liabilities
1.66
2.17
Long Term Trade Payables
0.00
0.00
Long Term Provisions
0.67
0.46
Total Non-Current Liabilities
28.56
16.79
Current Liabilities
Trade Payables
71.29
93.71
Other Current Liabilities
31.99
38.43
Short Term Borrowings
17.48
8.55
Short Term Provisions
0.77
0.42
Total Current Liabilities
121.53
141.11
Total Liabilities
432.64
333.11
ASSETS
Non-Current Assets
0.00
0.00
Gross Block
16.27
12.88
Less: Accumulated Depreciation
2.61
1.85
Less : Impairment of Assets
0.00
0.00
Net Block
13.66
11.03
Lease Adjustment
0.00
0.00
Capital Work in Progress
0.00
0.01
Intangible assets under development
0.06
0.00
Pre-operative Expenses pending
0.00
0.00
Assets in transit
0.00
0.00
Non Current Investments
186.12
104.38
Long Term Loans & Advances
9.33
2.60
Other Non Current Assets
0.00
0.00
Total Non-Current Assets
211.27
120.78
Current Assets Loans & Advances
Current Investments
0.00
0.14
Inventories
51.56
43.11
Sundry Debtors
108.03
115.29
Cash and Bank
8.14
13.85
Other Current Assets
0.32
0.04
Short Term Loans and Advances
53.32
39.90
Total Current Assets
221.37
212.33
Net Current Assets (Including Current Investments)
99.84
71.22
Total Current Assets Excluding Current Investments
221.37
212.19
Miscellaneous Expenses not written off
0.00
0.00
Total Assets
432.64
333.11
Contingent Liabilities
0.00
75.35
Total Debt
20.45
11.34
Book Value per share (adjusted)
217.2
134.09
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 80.17% vs NA in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is -23.50% vs NA in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 23.73% vs NA in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 78.31% vs NA in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 4.26% vs NA in Mar 2024
Compare Balance Sheet Results of Remus Pharma.
Figures in Cr
Consolidated - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.89
9.20
-3.31
-35.98%
Share Warrants & Outstandings
Total Reserve
249.97
393.40
-143.43
-36.46%
Shareholder's Funds
255.86
402.60
-146.74
-36.45%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.69
18.61
-14.92
-80.17%
Secured Loans
2.14
16.39
-14.25
-86.94%
Unsecured Loans
1.55
2.22
-0.67
-30.18%
Deferred Tax Assets / Liabilities
22.90
8.83
14.07
159.34%
Other Long Term Liabilities
1.66
0.00
1.66
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.67
1.86
-1.19
-63.98%
Total Non-Current Liabilities
28.56
29.31
-0.75
-2.56%
Current Liabilities
Trade Payables
71.29
51.44
19.85
38.59%
Other Current Liabilities
31.99
38.51
-6.52
-16.93%
Short Term Borrowings
17.48
64.38
-46.90
-72.85%
Short Term Provisions
0.77
1.80
-1.03
-57.22%
Total Current Liabilities
121.53
156.12
-34.59
-22.16%
Total Liabilities
432.64
588.03
-155.39
-26.43%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
16.27
249.48
-233.21
-93.48%
Less: Accumulated Depreciation
2.61
77.12
-74.51
-96.62%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
13.66
172.36
-158.70
-92.07%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
2.51
-2.51
-100.00%
Intangible assets under development
0.06
0.00
0.06
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
186.12
94.77
91.35
96.39%
Long Term Loans & Advances
9.33
13.34
-4.01
-30.06%
Other Non Current Assets
0.00
1.18
-1.18
-100.00%
Total Non-Current Assets
211.27
284.17
-72.90
-25.65%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
51.56
84.31
-32.75
-38.84%
Sundry Debtors
108.03
177.10
-69.07
-39.00%
Cash and Bank
8.14
12.84
-4.70
-36.60%
Other Current Assets
0.32
6.81
-6.49
-95.30%
Short Term Loans and Advances
53.32
22.80
30.52
133.86%
Total Current Assets
221.37
303.87
-82.50
-27.15%
Net Current Assets (Including Current Investments)
99.84
147.74
-47.90
-32.42%
Total Current Assets Excluding Current Investments
221.37
303.87
-82.50
-27.15%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
432.64
588.03
-155.39
-26.43%
Contingent Liabilities
0.00
25.85
-25.85
-100.00%
Total Debt
20.45
82.99
-62.54
-75.36%
Book Value per share (adjusted)
217.20
40.16
177.04
440.84%
Annual - Borrowings
Borrowings 20.81 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 80.17% vs NA in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 1.66 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -23.50% vs NA in Mar 2024
Annual - Fixed Assets
Fixed Assets 13.66 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 23.73% vs NA in Mar 2024
Annual - Investments
Investments 186.12 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 78.31% vs NA in Mar 2024
Annual - Current Assets
Current Assets 221.37 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 4.26% vs NA in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
